Pharmacokinetics and Tolerability of Sulthiame

Summary

This preliminary pilot exploration aims at specifying the pharmacokinetic parameters of sulthiame, formulated as an immediate release tablet, thus helping to design proper clinical trials for the future assessment of new paediatric formulations currently under development. The clinical tolerability to single doses of sulthiame will also be closely monitored to orient future trials.

Timeline

Start

2018-02-12

Primary completion

2018-05-22

Completion

2018-08-30

Drugs

Indications